320 related articles for article (PubMed ID: 17368986)
1. Antifolates can have a role in the treatment of Plasmodium vivax.
Hawkins VN; Joshi H; Rungsihirunrat K; Na-Bangchang K; Sibley CH
Trends Parasitol; 2007 May; 23(5):213-22. PubMed ID: 17368986
[TBL] [Abstract][Full Text] [Related]
2. Molecular epidemiology of malaria in Cameroon. XXVII. Clinical and parasitological response to sulfadoxine-pyrimethamine treatment and Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase alleles in Cameroonian children.
Tahar R; Basco LK
Acta Trop; 2007 Aug; 103(2):81-9. PubMed ID: 17640607
[TBL] [Abstract][Full Text] [Related]
3. Island-wide diversity in single nucleotide polymorphisms of the Plasmodium vivax dihydrofolate reductase and dihydropteroate synthetase genes in Sri Lanka.
Schousboe ML; Rajakaruna RS; Salanti A; Hapuarachchi HC; Galappaththy GN; Bygbjerg IC; Amerasinghe PH; Konradsen F; Alifrangis M
Malar J; 2007 Mar; 6():28. PubMed ID: 17349045
[TBL] [Abstract][Full Text] [Related]
4. High prevalence and fixation of Plasmodium vivax dhfr/dhps mutations related to sulfadoxine/pyrimethamine resistance in French Guiana.
Barnadas C; Musset L; Legrand E; Tichit M; Briolant S; Fusai T; Rogier C; Bouchier C; Picot S; Ménard D
Am J Trop Med Hyg; 2009 Jul; 81(1):19-22. PubMed ID: 19556560
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria.
Happi CT; Gbotosho GO; Folarin OA; Akinboye DO; Yusuf BO; Ebong OO; Sowunmi A; Kyle DE; Milhous W; Wirth DF; Oduola AM
Acta Trop; 2005 Sep; 95(3):183-93. PubMed ID: 16023986
[TBL] [Abstract][Full Text] [Related]
6. Dihydrofolate reductase mutations in Plasmodium vivax from Indonesia and therapeutic response to sulfadoxine plus pyrimethamine.
Hastings MD; Porter KM; Maguire JD; Susanti I; Kania W; Bangs MJ; Sibley CH; Baird JK
J Infect Dis; 2004 Feb; 189(4):744-50. PubMed ID: 14767830
[TBL] [Abstract][Full Text] [Related]
7. Plasmodium falciparum dhfr but not dhps mutations associated with sulphadoxine-pyrimethamine treatment failure and gametocyte carriage in northern Ghana.
Mockenhaupt FP; Teun Bousema J; Eggelte TA; Schreiber J; Ehrhardt S; Wassilew N; Otchwemah RN; Sauerwein RW; Bienzle U
Trop Med Int Health; 2005 Sep; 10(9):901-8. PubMed ID: 16135198
[TBL] [Abstract][Full Text] [Related]
8. Amino acid mutations in Plasmodium vivax DHFR and DHPS from several geographical regions and susceptibility to antifolate drugs.
Auliff A; Wilson DW; Russell B; Gao Q; Chen N; Anh le N; Maguire J; Bell D; O'Neil MT; Cheng Q
Am J Trop Med Hyg; 2006 Oct; 75(4):617-21. PubMed ID: 17038682
[TBL] [Abstract][Full Text] [Related]
9. Limited polymorphism in the dihydropteroate synthetase gene (dhps) of Plasmodium vivax isolates from Thailand.
Imwong M; Pukrittayakamee S; Cheng Q; Moore C; Looareesuwan S; Snounou G; White NJ; Day NP
Antimicrob Agents Chemother; 2005 Oct; 49(10):4393-5. PubMed ID: 16189131
[TBL] [Abstract][Full Text] [Related]
10. Molecular assessment of dhfr/dhps mutations among Plasmodium vivax clinical isolates after introduction of sulfadoxine/pyrimethamine in combination with artesunate in Iran.
Afsharpad M; Zakeri S; Pirahmadi S; Djadid ND
Infect Genet Evol; 2012 Jan; 12(1):38-44. PubMed ID: 22020253
[TBL] [Abstract][Full Text] [Related]
11. Two mutations in dihydrofolate reductase combined with one in the dihydropteroate synthase gene predict sulphadoxine-pyrimethamine parasitological failure in Ugandan children with uncomplicated falciparum malaria.
Talisuna AO; Nalunkuma-Kazibwe A; Langi P; Mutabingwa TK; Watkins WW; Van Marck E; Egwang TG; D'Alessandro U
Infect Genet Evol; 2004 Dec; 4(4):321-7. PubMed ID: 15374529
[TBL] [Abstract][Full Text] [Related]
12. Point mutations in the dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum and resistance to sulfadoxine-pyrimethamine in Sri Lanka.
Hapuarachchi HC; Dayanath MY; Bandara KB; Abeysundara S; Abeyewickreme W; de Silva NR; Hunt SY; Sibley CH
Am J Trop Med Hyg; 2006 Feb; 74(2):198-204. PubMed ID: 16474070
[TBL] [Abstract][Full Text] [Related]
13. Sequence variations in the genes encoding dihydropteroate synthase and dihydrofolate reductase and clinical response to sulfadoxine-pyrimethamine in patients with acute uncomplicated falciparum malaria.
Basco LK; Tahar R; Keundjian A; Ringwald P
J Infect Dis; 2000 Aug; 182(2):624-8. PubMed ID: 10915101
[TBL] [Abstract][Full Text] [Related]
14. Associations of antifolate resistance in vitro and point mutations in dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum.
Biswas S
J Postgrad Med; 2004; 50(1):17-20. PubMed ID: 15047993
[TBL] [Abstract][Full Text] [Related]
15. Patterns of resistance and DHFR/DHPS genotypes of Plasmodium falciparum in rural Tanzania prior to the adoption of sulfadoxine-pyrimethamine as first-line treatment.
Eriksen J; Mwankusye S; Mduma S; Kitua A; Swedberg G; Tomson G; Gustafsson LL; Warsame M
Trans R Soc Trop Med Hyg; 2004 Jun; 98(6):347-53. PubMed ID: 15099990
[TBL] [Abstract][Full Text] [Related]
16. Distribution of Plasmodium vivax pvdhfr and pvdhps alleles and their association with sulfadoxine-pyrimethamine treatment outcomes in Indonesia.
Asih PB; Marantina SS; Nababan R; Lobo NF; Rozi IE; Sumarto W; Dewi RM; Tuti S; Taufik AS; Mulyanto ; Sauerwein RW; Syafruddin D
Malar J; 2015 Sep; 14():365. PubMed ID: 26395428
[TBL] [Abstract][Full Text] [Related]
17. Plasmodium vivax: prevalence of mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium vivax clinical isolates from Pakistan.
Zakeri S; Afsharpad M; Ghasemi F; Raeisi A; Kakar Q; Atta H; Djadid ND
Exp Parasitol; 2011 Jan; 127(1):167-72. PubMed ID: 20655913
[TBL] [Abstract][Full Text] [Related]
18. Antimalarial resistance and DHFR/DHPS genotypes of Plasmodium falciparum three years after introduction of sulfadoxine-pyrimethamine and amodiaquine in rural Tanzania.
Eriksen J; Mwankusye S; Mduma S; Veiga MI; Kitua A; Tomson G; Petzold MG; Swedberg G; Gustafsson LL; Warsame M
Trans R Soc Trop Med Hyg; 2008 Feb; 102(2):137-42. PubMed ID: 18082233
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in vivo resistance.
Mugittu K; Ndejembi M; Malisa A; Lemnge M; Premji Z; Mwita A; Nkya W; Kataraihya J; Abdulla S; Beck HP; Mshinda H
Am J Trop Med Hyg; 2004 Dec; 71(6):696-702. PubMed ID: 15642957
[TBL] [Abstract][Full Text] [Related]
20. Relationship between age, molecular markers, and response to sulphadoxine-pyrimethamine treatment in Kampala, Uganda.
Staedke SG; Sendagire H; Lamola S; Kamya MR; Dorsey G; Rosenthal PJ
Trop Med Int Health; 2004 May; 9(5):624-9. PubMed ID: 15117308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
